-
Mashup Score: 4ASCO Releases Vaccination Guidelines for Adults With Cancer - 1 month(s) ago
Oncologists may be key in ensuring patients with cancer safely receive vaccinations and avert avoidable infections.
Source: www.mdedge.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0John Lennon's son Sean Lennon wins Oscar and pays emotional tribute to his mother Yoko Ono - 2 month(s) ago
A touching moment at the 2024 Oscars saw Sean Ono Lennon pick up a prize and pay tribute to his mother Yoko.
Source: www.goldradiouk.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Pan-cancer proteogenomics characterization of tumor immunity - 2 month(s) ago
Despite the successes of immunotherapy in cancer treatment over recent decades, less than <10%–20% cancer cases have demonstrated durable responses fr…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4An Open Letter to End Drug Shortages - 2 month(s) ago
Sign the letter and urge policymakers to end drug shortages!
Source: asco.quorum.usCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.
Source: www.mdedge.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.
Source: www.mdedge.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Despite the remarkable success of anti-cancer immunotherapy, its effectiveness remains confined to a subset of patients—emphasizing the importance of …
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Where Is the ‘Microbiome Revolution’ Headed Next? - 4 month(s) ago
Important advances are coming our way in the next 5-10 years.
Source: www.mdedge.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy - 4 month(s) ago
Immunohistochemistry (IHC) is currently the first-line test for mismatch repair deficiency (MMR-D). Bou Farhat et al. show that mismatch repair (MMR) mutation signature by next-generation sequencing is a highly sensitive assay capable of detecting MMR-D cases that are missed in 1% and 5% of patients with MMR-D colorectal cancer (CRC) and endometrial cancer (EC), respectively. Patients with MMR-D tumors missed by IHC have similar clinical outcomes to patients with MMR-D by both IHC and mutation signature.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Rectal cancer in the United States is increasingly being managed without the use of surgery, leading to higher rates of organ preservation.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Hem/OncsTweet
ASCO Releases Vaccination Guidelines for Adults With Cancer https://t.co/n92b6bn2zQ